For their OTC business, the most innovative pharma companies are following consumer products companies: capturing vast amounts of demand-related information which is then fed into sophisticated ...

USA-based Endo Inc (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its international ...

Glenmark Pharmaceuticals launches polyethylene glycol 3350, a constipation treatment medicine in the US. The OTC product aims ...

Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for ...

OTC Markets Group announced today that its Board of Directors authorized and approved a quarterly cash dividend of $0.18 per share of Class A Common Stock. The quarterly cash dividend is payable on ...

Glenmark Pharmaceuticals has announced the launch of 'Polyethylene Glycol 3350 Powder for Solution' as on OTC product in the US market.

Glenmark Pharmaceuticals has introduced a new constipation treatment, polyethylene glycol 3350 powder, to the US market. This launch aims to fulfill the rising demand for a fresh supplier in the ...

Commenting on the launch, Marc Kikuchi, President & Business Head ... global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...